Meydan Sezen, Klepacki Dorota, Mankin Alexander S, Vázquez-Laslop Nora
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL, USA.
Methods Mol Biol. 2021;2252:27-55. doi: 10.1007/978-1-0716-1150-0_2.
The knowledge of translation start sites is crucial for annotation of genes in bacterial genomes. However, systematic mapping of start codons in bacterial genes has mainly relied on predictions based on protein conservation and mRNA sequence features which, although useful, are not always accurate. We recently found that the pleuromutilin antibiotic retapamulin (RET) is a specific inhibitor of translation initiation that traps ribosomes specifically at start codons, and we used it in combination with ribosome profiling to map start codons in the Escherichia coli genome. This genome-wide strategy, that was named Ribo-RET, not only verifies the position of start codons in already annotated genes but also enables identification of previously unannotated open reading frames and reveals the presence of internal start sites within genes. Here, we provide a detailed Ribo-RET protocol for E. coli. Ribo-RET can be adapted for mapping the start codons of the protein-coding sequences in a variety of bacterial species.
翻译起始位点的知识对于细菌基因组中的基因注释至关重要。然而,细菌基因中起始密码子的系统定位主要依赖于基于蛋白质保守性和mRNA序列特征的预测,这些预测虽然有用,但并不总是准确的。我们最近发现,截短侧耳素类抗生素瑞他帕林(RET)是翻译起始的特异性抑制剂,可将核糖体特异性捕获在起始密码子处,并且我们将其与核糖体图谱分析相结合来定位大肠杆菌基因组中的起始密码子。这种全基因组策略被命名为Ribo-RET,它不仅验证了已注释基因中起始密码子的位置,还能够鉴定先前未注释的开放阅读框,并揭示基因内部起始位点的存在。在这里,我们提供了一份详细的针对大肠杆菌的Ribo-RET实验方案。Ribo-RET可适用于绘制多种细菌物种中蛋白质编码序列的起始密码子图谱。